Profile: Biochemical Diagnostics, Inc. specializes in offering column hardware, liquid urine controls, thin layer chromatography, and microtiter configured sample preparation hardware. The Detectabuse controls are designed to monitor and validate the performance of drugs of abuse detection methods at levels established by SAMHSA, CAP/AACC & many state programs. The Detectabuse control urines are compatible with all quantitative and qualitative drug detection procedures which are sufficiently sensitive to detect the control constituents. This product is intended to be used by health care professionals as an integral part of good laboratory practices. Pregnancy-Skreen™ controls are prepared from human based urine available as a negative and at positive hCG levels to qualitatively monitor the performance of urine pregnancy immunochromatographic detection devices & procedures. The Pregnancy-Skreen™ product line of controls is manufactured using a human based urine matrix that has been stabilized to insure that the product will be viable until the date of expiration. The positive control is spiked with hCG in a target range from 200-400 mIU/mL of urine matrix. The negative control is prepared from a urine pool that tested negative for hCG. We offer Multi-Prep® Gravity series GVSA column methods for the analysis of methylmalonic acid and homocysteine in serum using GC-MS. These methods involve sample preparation on the Multi-Prep GVSA column, a strong anion exchange gravity flow column, and measurement by GC-MS using MMA-D3 and Homocystine-D8 as internal standards. Homocysteine is protected from oxidation with the use of a proprietary stabilizer.

The company was founded in 1981, has revenues of USD 1-5 Million, has ~20 employees and is CE certified.

FDA Registration Number: 2432495